INTERCEPT PHARMACEUTICALS, INC. Annual Operating Lease, Payments in USD from 2019 to 2021

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Intercept Pharmaceuticals, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2021.
  • Intercept Pharmaceuticals, Inc. Operating Lease, Payments for the quarter ending March 31, 2022 was $1.7M, a 22.7% decline year-over-year.
  • Intercept Pharmaceuticals, Inc. annual Operating Lease, Payments for 2021 was $7.7M, a 2.53% decline from 2020.
  • Intercept Pharmaceuticals, Inc. annual Operating Lease, Payments for 2020 was $7.9M, a 5.33% increase from 2019.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 $7.7M -$200K -2.53% Jan 1, 2021 Dec 31, 2021 10-K 2022-03-02
2020 $7.9M +$400K +5.33% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-02
2019 $7.5M Jan 1, 2019 Dec 31, 2019 10-K 2022-03-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.